These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17958982)

  • 41. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E; De Silvestri A; Boschi A; Tinelli C
    AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.
    Nettles RE; Mazo D; Alwood K; Gachuhi R; Maltas G; Wendel K; Cronin W; Hooper N; Bishai W; Sterling TR
    Clin Infect Dis; 2004 Mar; 38(5):731-6. PubMed ID: 14986259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.
    Shin SS; Pasechnikov AD; Gelmanova IY; Peremitin GG; Strelis AK; Mishustin S; Barnashov A; Karpeichik Y; Andreev YG; Golubchikova VT; Tonkel TP; Yanova GV; Yedilbayev A; Rich ML; Mukherjee JS; Furin JJ; Atwood S; Farmer PE; Keshavjee S
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1314-20. PubMed ID: 18034952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study.
    Lorent N; Sebatunzi O; Mukeshimana G; Van den Ende J; Clerinx J
    PLoS One; 2011; 6(5):e19566. PubMed ID: 21611117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs.
    Tan WC; Ong CK; Kang SC; Razak MA
    Med J Malaysia; 2007 Jun; 62(2):143-6. PubMed ID: 18705448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of tuberculosis: present status and future prospects.
    Onyebujoh P; Zumla A; Ribeiro I; Rustomjee R; Mwaba P; Gomes M; Grange JM
    Bull World Health Organ; 2005 Nov; 83(11):857-65. PubMed ID: 16302043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study of pulmonary tuberculosis in the elderly.
    Das SK; Mukherjee RS; Ghosh IN; Halder AK; Saha SK
    J Indian Med Assoc; 2007 Aug; 105(8):432, 436, 438-9. PubMed ID: 18236905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.
    Tabarsi P; Chitsaz E; Moradi A; Baghaei P; Farnia P; Marjani M; Irannejad P; Mansouri D; Masjedi M
    Int J STD AIDS; 2009 Aug; 20(8):566-70. PubMed ID: 19625590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of pulmonary tuberculosis with increased dietary iron.
    Gangaidzo IT; Moyo VM; Mvundura E; Aggrey G; Murphree NL; Khumalo H; Saungweme T; Kasvosve I; Gomo ZA; Rouault T; Boelaert JR; Gordeuk VR
    J Infect Dis; 2001 Oct; 184(7):936-9. PubMed ID: 11528590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL.
    Manosuthi W; Sungkanuparph S; Tansuphaswadikul S; Chottanapund S; Mankatitham W; Chimsuntorn S; Sittibusaya C; Moolasart V; Chaovavanich A
    J Med Assoc Thai; 2008 Feb; 91(2):159-65. PubMed ID: 18389979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors contributing to treatment success among tuberculosis patients: a prospective cohort study in Bangkok.
    Okanurak K; Kitayaporn D; Akarasewi P
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1160-5. PubMed ID: 18812046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Predictive factors of non-compliance with anti-tuberculosis treatment in patients infected with the human immunodeficiency virus].
    Pulido Ortega F; Sánchez de Rivera JM; Rubio García R; González García J; Costa Pérez-Herrero JR; Vázquez Rodríguez JJ; del Palacio Pérez-Medel A
    Rev Clin Esp; 1997 Mar; 197(3):163-6. PubMed ID: 9273580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients.
    Lehloenya RJ; Wallace J; Todd G; Dheda K
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1260-4. PubMed ID: 22747953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.
    Tansuphasawadikul S; Saito W; Kim J; Phonrat B; Dhitavat J; Chamnachanan S; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):1053-60. PubMed ID: 18613546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?
    Dubrovina I; Miskinis K; Lyepshina S; Yann Y; Hoffmann H; Zaleskis R; Nunn P; Zignol M
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):756-62. PubMed ID: 18544200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
    Shores NJ; Maida I; Soriano V; Núnez M
    J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.